294 related articles for article (PubMed ID: 10342828)
1. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
Bodine PV; Harris HA; Komm BS
Endocrinology; 1999 Jun; 140(6):2439-51. PubMed ID: 10342828
[TBL] [Abstract][Full Text] [Related]
2. Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line.
Bodine PV; Green J; Harris HA; Bhat RA; Stein GS; Lian JB; Komm BS
J Cell Biochem; 1997 Jun; 65(3):368-87. PubMed ID: 9138093
[TBL] [Abstract][Full Text] [Related]
3. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
4. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids.
Rifas L; Kenney JS; Marcelli M; Pacifici R; Cheng SL; Dawson LL; Avioli LV
Endocrinology; 1995 Sep; 136(9):4056-67. PubMed ID: 7649114
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells.
Kurokouchi K; Kambe F; Yasukawa K; Izumi R; Ishiguro N; Iwata H; Seo H
J Bone Miner Res; 1998 Aug; 13(8):1290-9. PubMed ID: 9718198
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
7. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
Gionet N; Jansson D; Mader S; Pratt MA
J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
[TBL] [Abstract][Full Text] [Related]
9. Effect of 17beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes.
Takao T; Kumagai C; Hisakawa N; Matsumoto R; Hashimoto K
J Endocrinol; 2005 Jan; 184(1):191-7. PubMed ID: 15642795
[TBL] [Abstract][Full Text] [Related]
10. Expression of functional estrogen receptors and galanin messenger ribonucleic acid in immortalized luteinizing hormone-releasing hormone neurons: estrogenic control of galanin gene expression.
Shen ES; Meade EH; Pérez MC; Deecher DC; Negro-Vilar A; López FJ
Endocrinology; 1998 Mar; 139(3):939-48. PubMed ID: 9492023
[TBL] [Abstract][Full Text] [Related]
11. 17beta-estradiol inhibits the production of RANTES in human keratinocytes.
Kanda N; Watanabe S
J Invest Dermatol; 2003 Mar; 120(3):420-7. PubMed ID: 12603855
[TBL] [Abstract][Full Text] [Related]
12. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
13. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol.
Chaudhary LR; Spelsberg TC; Riggs BL
Endocrinology; 1992 May; 130(5):2528-34. PubMed ID: 1572280
[TBL] [Abstract][Full Text] [Related]
14. Calcium signaling pathway involving calcineurin regulates interleukin-8 gene expression through activation of NF-kappaB in human osteoblast-like cells.
Mitsuyama H; Kambe F; Murakami R; Cao X; Ishiguro N; Seo H
J Bone Miner Res; 2004 Apr; 19(4):671-9. PubMed ID: 15005855
[TBL] [Abstract][Full Text] [Related]
15. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
[TBL] [Abstract][Full Text] [Related]
16. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
[TBL] [Abstract][Full Text] [Related]
17. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
18. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
Hofbauer LC; Ten RM; Khosla S
J Bone Miner Res; 1999 Aug; 14(8):1330-7. PubMed ID: 10457265
[TBL] [Abstract][Full Text] [Related]
19. Activation of transcriptionally active nuclear factor-kappaB by tumor necrosis factor-alpha and its inhibition by antioxidants in rat thyroid FRTL-5 cells.
Kikumori T; Kambe F; Nagaya T; Imai T; Funahashi H; Seo H
Endocrinology; 1998 Apr; 139(4):1715-22. PubMed ID: 9528954
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
Ock S; Ahn J; Lee SH; Park H; Son JW; Oh JG; Yang DK; Lee WS; Kim HS; Rho J; Oh GT; Abel ED; Park WJ; Min JK; Kim J
Cardiovasc Res; 2012 Apr; 94(1):105-14. PubMed ID: 22298642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
